Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

5509 reported adverse events

Drugs of this class: GANCICLOVIR

These side effects are most commonly reported by patients taking drugs of the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class:

# Side effect Count
0 CYTOMEGALOVIRUS INFECTION 751
1 DRUG INEFFECTIVE 554
2 OFF LABEL USE 475
3 PYREXIA 408
4 DRUG RESISTANCE 327
5 DIARRHOEA 295
6 PRODUCT USE IN UNAPPROVED INDICATION 290
7 SEPSIS 274
8 PNEUMONIA 272
9 NEUTROPENIA 249
See all common reactions for Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

Drugs of the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDITIS TOXOPLASMAL 5 0.5000
1 CYTOMEGALOVIRUS SYNDROME 43 0.3739
2 ENCEPHALITIS CYTOMEGALOVIRUS 70 0.3518
3 FLAVOBACTERIUM INFECTION 9 0.3462
4 SMOOTH MUSCLE CELL NEOPLASM 39 0.2690
5 GASTROINTESTINAL MUCORMYCOSIS 5 0.2500
6 ENCEPHALITIS JAPANESE B 4 0.2500
7 HIV ASSOCIATED NEPHROPATHY 6 0.2143
8 SCOPULARIOPSIS INFECTION 6 0.2069
9 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 30 0.1840
See all enriched reactions for Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]